76448 Federal Register / Vol. 69, No. 244 / Tuesday, December 21, 2004 / Notices 

validity of the methodology and 

assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) Minimize the burden of the 

information collection on those who are 

to respond, through use, as appropriate, 

of automated, electronic, mechanical, 

and other collection technologies, e.g., 

permitting electronic submission of 

responses. 

Estimate of burden: The public 

reporting burden for this collection of 

information is estimated to average 

0.7322 hours per response. 

Respondents: U.S. importers of fruits 

and vegetables and plant health officials 

of exporting countries. 

Estimated annual number of 

respondents: 822. 

Estimated annual number of 

responses per respondent: 2.2311. 

Estimated annual number of 

responses: 1,834. 

Estimated total annual burden on 

respondents: 1,343 hours. (Due to 

averaging, the total annual burden hours 

may not equal the product of the annual 

number of responses multiplied by the 

reporting burden per response.) 

All responses to this notice will be 

summarized and included in the request 

for OMB approval. All comments will 

also become a matter of public record.

Done in Washington, DC, this 14th day of 

December, 2004. 

Elizabeth E. Gaston, 

Acting Administrator, Animal and Plant 

Health Inspection Service.

[FR Doc. 04–27880 Filed 12–20–04; 8:45 am] 

BILLING CODE 3410–34–P

DEPARTMENT OF AGRICULTURE

Animal and Plant Health Inspection 

Service 

[Docket No. 04–084–1] 

Availability of an Environmental 

Assessment for Field Testing Equine 

Influenza Vaccine, Live Canarypox 

Vector

AGENCY: Animal and Plant Health 

Inspection Service, USDA.

ACTION: Notice.

SUMMARY: We are advising the public 

that the Animal and Plant Health 

Inspection Service has prepared an 

environmental assessment concerning 

authorization to ship for the purpose of 

field testing, and then to field test, an 

unlicensed Equine Influenza Vaccine, 

Live Canarypox Vector for use in horses. 

The environmental assessment, which is 

based on a risk analysis prepared to 

assess the risks associated with the field 

testing of this vaccine, examines the 

potential effects that field testing this 

veterinary vaccine could have on the 

quality of the human environment. 

Based on the risk analysis, we have 

reached a preliminary determination 

that field testing this veterinary vaccine 

will not have a significant impact on the 

quality of the human environment, and 

that an environmental impact statement 

need not be prepared. We intend to 

authorize shipment of this vaccine for 

field testing following the close of the 

comment period for this notice unless 

new substantial issues bearing on the 

effects of this action are brought to our 

attention. We also intend to issue a U.S. 

Veterinary Biological Product license for 

this vaccine, provided the field test data 

support the conclusions of the 

environmental assessment and the 

issuance of a finding of no significant 

impact and the product meets all other 

requirements for licensing.

DATES: We will consider all comments 

that we receive on or before January 20, 

2005.

ADDRESSES: You may submit comments 

by any of the following methods: 

• EDOCKET: Go to http://

www.epa.gov/feddocket to submit or 

view public comments, access the index 

listing of the contents of the official 

public docket, and to access those 

documents in the public docket that are 

available electronically. Once you have 

entered EDOCKET, click on the ‘‘View 

Open APHIS Dockets’’ link to locate this 

document. 

• Postal Mail/Commercial Delivery: 

Please send four copies of your 

comment (an original and three copies) 

to: Docket No. 04–084–1, Regulatory 

Analysis and Development, PPD, 

APHIS, Station 3C71, 4700 River Road 

Unit 118, Riverdale, MD 20737–1238. 

Please state that your comment refers to 

Docket No. 04–084–1. 

• E-Mail: Address your comment to 

regulations@aphis.usda.gov. Your 

comment must be contained in the body 

of your message; do not send attached 

files. Please include your name and 

address in your message and ‘‘Docket 

No. 04–084–1’’ on the subject line. 

• Federal eRulemaking Portal: Go to 

http://www.regulations.gov and follow 

the instructions for locating this docket 

and submitting comments. 

Reading Room: You may read the 

environmental assessment, the risk 

analysis (with confidential business 

information removed), and any 

comments that we receive in our 

reading room. The reading room is 

located in room 1141 of the USDA 

South Building, 14th Street and 

Independence Avenue, SW., 

Washington, DC. Normal reading room 

hours are 8 a.m. to 4:30 p.m., Monday 

through Friday, except holidays. To be 

sure someone is there to help you, 

please call (202) 690–2817 before 

coming.

Other Information: You may view 

APHIS documents published in the 

Federal Register and related 

information, including the names of 

groups and individuals who have 

commented on APHIS dockets, on the 

Internet at http://www.aphis.usda.gov/

ppd/rad/webrepor.html.

FOR FURTHER INFORMATION CONTACT: Dr. 

Albert P. Morgan, Chief Staff Officer, 

Operational Support Section, Center for 

Veterinary Biologics, Policy, Evaluation, 

and Licensing, VS, APHIS, 4700 River 

Road Unit 148, Riverdale, MD 20737–

1231; phone (301) 734–8245, fax (301) 

734–4314. 

For information regarding the 

environmental assessment or the risk 

analysis, or to request a copy of the 

environmental assessment (as well as 

the risk analysis with confidential 

business information removed), contact 

Dr. Louise M. Henderson, Center for 

Veterinary Biologics, Policy, Evaluation, 

and Licensing VS, APHIS, 510 South 

17th Street, Suite 104, Ames, IA 50010; 

phone (515) 232–5785, fax (515) 232–

7120.

SUPPLEMENTARY INFORMATION: Under the 

Virus-Serum-Toxin Act (21 U.S.C. 151 

et seq.), a veterinary biological product 

must be shown to be pure, safe, potent, 

and efficacious before a veterinary 

biological product license may be 

issued. A field test is generally 

necessary to satisfy prelicensing 

requirements for veterinary biological 

products. Prior to conducting a field test 

on an unlicensed product, an applicant 

must obtain approval from the Animal 

and Plant Health Inspection Service 

(APHIS), as well as obtain APHIS’

authorization to ship the product for 

field testing. 

To determine whether to authorize 

shipment and grant approval for the 

field testing of the unlicensed product 

referenced in this notice, APHIS 

conducted a risk analysis to assess the 

potential effects of this product on the 

safety of animals, public health, and the 

environment. Based on the risk analysis, 

APHIS has prepared an environmental 

assessment (EA) concerning the field 

testing of the following unlicensed 

veterinary biological product: 

Requester: Merial Limited. 

Product: Equine Influenza Vaccine, 

Live Canarypox Vector. 

Federal Register / Vol. 69, No. 244 / Tuesday, December 21, 2004 / Notices 76449

Field Test Locations: Montana, 

Oklahoma, Iowa, Missouri, Tennessee, 

and Florida. 

The above-mentioned product is a 

live canarypox vector that has been 

genetically modified to express genes 

from two equine influenza virus strains. 

The vaccine is for use in horses as an 

aid in the prevention of disease caused 

by equine influenza virus. 

The EA has been prepared in 

accordance with: (1) The National 

Environmental Policy Act of 1969 

(NEPA), as amended (42 U.S.C. 4321 et 

seq.), (2) regulations of the Council on 

Environmental Quality for 

implementing the procedural provision 

of NEPA (40 CFR parts 1500–1508), (3) 

USDA regulations implementing NEPA 

(7 CFR part 1b), and (4) APHIS’ NEPA 

Implementing Procedures (7 CFR part 

372). 

Unless substantial issues with adverse 

environmental impacts are raised in 

response to this notice, APHIS intends 

to issue a finding of no significant 

impact (FONSI) based on the EA and 

authorize shipment of the above product 

for the initiation of field tests following 

the close of the comment period for this 

notice. 

Because the issues raised by field 

testing and by issuance of a license are 

identical, APHIS has concluded that the 

EA that is generated for field testing 

would also be applicable to the 

proposed licensing action. Provided that 

the field test data support the 

conclusions of the original EA and the 

issuance of a FONSI, APHIS does not 

intend to issue a separate EA and FONSI 

to support the issuance of the product 

license, and would determine that an 

environmental impact statement need 

not be prepared. APHIS intends to issue 

a veterinary biological product license 

for this vaccine following completion of 

the field test provided no adverse 

impacts on the human environment are 

identified and provided the product 

meets all other requirements for 

licensing.

Authority: 21 U.S.C. 151–159.

Done in Washington, DC, this 14th day of 

December 2004. 

Elizabeth E. Gaston, 

Acting Administrator, Animal and Plant 

Health Inspection Service.

[FR Doc. 04–27881 Filed 12–20–04; 8:45 am] 

BILLING CODE 3410–34–P

ARCTIC RESEARCH COMMISSION

Notice of Meeting 

Notice is hereby given that the U.S. 

Arctic Research Commission will hold 

its 74th Meeting in Arlington, VA on 

January 18–19, 2005. The Business 

Session open to the public will convene 

at 9 a.m. Tuesday, January 18, the 

Agenda items include: 

(1) Call to order and approval of the 

Agenda. 

(2) Approval of the Minutes of the 

73rd Meeting. 

(3) Reports from Congressional 

Liaisons. 

(4) Agency Reports. 

The focus of the Meeting will be 

reports and updates on programs and 

research projects affecting the Arctic. 

Presentations include a review of the 

research needs for civil infrastructure in 

Alaska. 

The Business Session will reconvene 

at 9 a.m. Wednesday, January 19, 2005. 

An Executive Session will follow 

adjournment of the Business Session. 

Any person planning to attend this 

meeting who requires special 

accessibility features and/or auxiliary 

aids, such as sign language interpreters 

must inform the Commission in advance 

of those needs. 

Contact Person for More Information: 

Dr. Garrett W. Brass, Executive Director, 

Arctic Research Commission, (703) 525–

0111 or TDD (703) 306–0090.

Garrett W. Brass, 

Executive Director.

[FR Doc. 04–27854 Filed 12–20–04; 8:45 am] 

BILLING CODE 7555–01–M

CENTRAL INTELLIGENCE AGENCY

Notice of Decennial Review of 

Operational Files Designations

AGENCY: Central Intelligence Agency.

ACTION: Notice of Decennial Review of 

Operational Files Designations. 

SUMMARY: The Central Intelligence 

Agency (CIA or Agency) is soliciting 

comments regarding the historical value 

of, or other public interest in, the CIA 

files designated by the Director of 

Central Intelligence (DCI) pursuant to 

the CIA Information Act of 1984.

DATES: Comments must be received by 

January 20, 2005.

ADDRESSES: Submit comments in 

writing to Edmund Cohen, Director of 

Information Management Services, 

Central Intelligence Agency, 

Washington, DC 20505, or by fax to 

(703) 613–3020.

FOR FURTHER INFORMATION CONTACT:

Edmund Cohen, Director of Information 

Management Services, Central 

Intelligence Agency, telephone 703–

613–1215.

SUPPLEMENTARY INFORMATION: The CIA 

Information Act of 1984, codified in 

section 431 of title 50 of the United 

States Code, authorizes the DCI to 

exempt operational files of the CIA from 

the publication, disclosure, search, and 

review provisions of the Freedom of 

Information Act. The statute defines 

operational files as: 

1. Files of the Directorate of 

Operations that document the conduct 

of foreign intelligence or 

counterintelligence operations or 

intelligence or security liaison 

arrangements or information exchanges 

with foreign governments or their 

intelligence or security services; 

2. Files of the Directorate of Science 

and Technology that document the 

means by which foreign intelligence or 

counterintelligence is collected through 

scientific and technical systems; and 

3. Files of the Office of Security that 

document investigations conducted to 

determine the suitability of potential 

foreign intelligence or 

counterintelligence sources; except that 

files that are the sole repository of 

disseminated intelligence are not 

operational files. 

The CIA Information Act of 1984 

requires that, not less than once every 

ten years, the DCI shall review the 

exemptions in force to determine 

whether such exemptions may be 

removed from any category of exempted 

files or any portion thereof. The Agency 

completed its first decennial review 

exercise in March 1995. The following 

represents a summary of the general 

categories of operational files that have 

been maintained within the Directorate 

of Operations, the Directorate of Science 

and Technology, and the Office of 

Security since the first decennial 

review: 

1. Files of the Directorate of 

Operations that document the 

intelligence sources and methods 

associated with various operational and 

foreign liaison activities, that document 

the conduct and management of various 

operational and foreign liaison 

activities, and that document the 

assessment of the viability of potential 

operational and foreign liaison activities 

and potential intelligence sources and 

methods; 

2. Files of the Directorate of Science 

and Technology that document the use 

of scientific and technical systems in 

the conduct of and in support of various 

operational and intelligence collection 

activities; 

3. Files of the Office of Security that 

document various aspects of the 

investigations conducted to determine 

the suitability of potential foreign 

intelligence or counterintelligence